Pharmacy PEP Access Intervention Among Persons Who Use Drugs in New York City: iPEPcare Study—Rethinking Biomedical HIV Prevention Strategies

Biomedical HIV prevention uptake has not taken hold among Black and Latinx populations who use street-marketed drugs. A pilot intervention providing a PEP informational video and direct pharmacy access to a PEP starter dose was conducted among this population. Four study pharmacies were selected to...

Full description

Saved in:
Bibliographic Details
Published in:AIDS and behavior 2020-07, Vol.24 (7), p.2101-2111
Main Authors: Lewis, Crystal Fuller, Lekas, Helen-Maria, Rivera, Alexis, Williams, Sharifa Z., Crawford, Natalie D., Pérez-Figueroa, Rafael E., Joseph, Adriana M., Amesty, Silvia
Format: Article
Language:English
Subjects:
Adult
Anti-HIV Agents - administration & dosage
Biomedicine
Disease prevention
Drug use
Drugs
Female
Health insurance
Health Knowledge, Attitudes, Practice
Health Psychology
Health risks
Health Services Accessibility
HIV
HIV Infections - prevention & control
Human immunodeficiency virus
Humans
Infectious Diseases
Male
Medicine
Medicine & Public Health
Mixed methods research
New York City
Original Paper
Pharmacies
Pharmacy
Population studies
Post-Exposure Prophylaxis - supply & distribution
Prevalence
Prevention
Psychosocial factors
Public Health
Recruitment
Risk behavior
Risk factors
Risk perception
Risk taking
Social Stigma
Stigma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Biomedical HIV prevention uptake has not taken hold among Black and Latinx populations who use street-marketed drugs. A pilot intervention providing a PEP informational video and direct pharmacy access to a PEP starter dose was conducted among this population. Four study pharmacies were selected to help facilitate syringe customer recruitment (2012–2016). Baseline, post-video, and 3-month ACASI captured demographic, risk behavior, and psychosocial factors associated with PEP willingness, and willingness to access PEP in a pharmacy. A non-experimental study design revealed baseline PEP willingness to be associated with PEP awareness, health insurance, being female, and having a high-risk partner (n = 454). Three-month PEP willingness was associated with lower HIV stigma (APR = 0.95). Using a pre-post approach, PEP knowledge (p 
ISSN:1090-7165
1573-3254
DOI:10.1007/s10461-019-02775-3